Annals of Pediatric Endocrinology & Metabolism最新文献

筛选
英文 中文
Cohort profile: Multicenter Networks for Ideal Outcomes of Rare Pediatric Endocrine and Metabolic Diseases in Korea (OUTSPREAD study). 队列概况:韩国罕见儿科内分泌和代谢疾病理想预后的多中心网络(OUTSPREAD研究)。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-12-01 Epub Date: 2024-12-31 DOI: 10.6065/apem.2448272.136
Yun Jeong Lee, Chong Kun Cheon, Junghwan Suh, Jung-Eun Moon, Moon Bae Ahn, Seong Hwan Chang, Jieun Lee, Jin Ho Choi, Minsun Kim, Han Hyuk Lim, Jaehyun Kim, Shin-Hye Kim, Hae Sang Lee, Yena Lee, Eungu Kang, Se Young Kim, Yong Hee Hong, Seung Yang, Heon-Seok Han, Sochung Chung, Won Kyoung Cho, Eun Young Kim, Jin Kyung Kim, Kye Shik Shim, Eun-Gyong Yoo, Hae Soon Kim, Aram Yang, Sejin Kim, Hyo-Kyoung Nam, Sung Yoon Cho, Young Ah Lee
{"title":"Cohort profile: Multicenter Networks for Ideal Outcomes of Rare Pediatric Endocrine and Metabolic Diseases in Korea (OUTSPREAD study).","authors":"Yun Jeong Lee, Chong Kun Cheon, Junghwan Suh, Jung-Eun Moon, Moon Bae Ahn, Seong Hwan Chang, Jieun Lee, Jin Ho Choi, Minsun Kim, Han Hyuk Lim, Jaehyun Kim, Shin-Hye Kim, Hae Sang Lee, Yena Lee, Eungu Kang, Se Young Kim, Yong Hee Hong, Seung Yang, Heon-Seok Han, Sochung Chung, Won Kyoung Cho, Eun Young Kim, Jin Kyung Kim, Kye Shik Shim, Eun-Gyong Yoo, Hae Soon Kim, Aram Yang, Sejin Kim, Hyo-Kyoung Nam, Sung Yoon Cho, Young Ah Lee","doi":"10.6065/apem.2448272.136","DOIUrl":"10.6065/apem.2448272.136","url":null,"abstract":"<p><p>Rare endocrine diseases are complex conditions that require lifelong specialized care due to their chronic nature and associated long-term complications. In Korea, a lack of nationwide data on clinical practice and outcomes has limited progress in patient care. Therefore, the Multicenter Networks for Ideal Outcomes of Pediatric Rare Endocrine and Metabolic Disease (OUTSPREAD) study was initiated. This study involves 30 centers across Korea. The study aims to improve the long-term prognosis of Korean patients with rare endocrine diseases by collecting comprehensive clinical data, biospecimens, and patient-reported outcomes to identify complications and unmet needs in patient care. Patients with childhood-onset pituitary, adrenal, or gonadal disorders, such as craniopharyngioma, congenital adrenal hyperplasia (CAH), and Turner syndrome were prioritized. The planned enrollment is 1,300 patients during the first study phase (2022-2024). Clinical, biochemical, and imaging data from diagnosis, treatment, and follow-up during 1980-2023 were retrospectively reviewed. For patients who agreed to participate in the prospective cohort, clinical data and biospecimens will be prospectively collected to discover ideal biomarkers that predict the effectiveness of disease control measures and prognosis. Patient-reported outcomes, including quality of life and depression scales, will be evaluated to assess psychosocial outcomes. Additionally, a substudy on CAH patients will develop a steroid hormone profiling method using liquid chromatography-tandem mass spectrometry to improve diagnosis and monitoring of treatment outcomes. This study will address unmet clinical needs by discovering ideal biomarkers, introducing evidence-based treatment guidelines, and ultimately improving long-term outcomes in the areas of rare endocrine and metabolic diseases.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 6","pages":"349-355"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725631/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carotid intima-media thickness as surrogate marker: the clouding effect of submillimetric inaccuracies. 作为替代标记的颈动脉内膜-中膜厚度:亚毫米误差的模糊效应。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-12-01 Epub Date: 2024-12-31 DOI: 10.6065/apem.2448226.113
Christian Saleh
{"title":"Carotid intima-media thickness as surrogate marker: the clouding effect of submillimetric inaccuracies.","authors":"Christian Saleh","doi":"10.6065/apem.2448226.113","DOIUrl":"10.6065/apem.2448226.113","url":null,"abstract":"","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 6","pages":"387-388"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and genetic features of childhood-onset congenital combined pituitary hormone deficiency: a retrospective, single-center cohort study. 儿童期先天性合并垂体激素缺乏症的临床和遗传特征:一项回顾性单中心队列研究
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-12-01 Epub Date: 2024-12-31 DOI: 10.6065/apem.2448008.004
Yoonha Lee, Young Ah Lee, Jung Min Ko, Choong Ho Shin, Yun Jeong Lee
{"title":"Clinical and genetic features of childhood-onset congenital combined pituitary hormone deficiency: a retrospective, single-center cohort study.","authors":"Yoonha Lee, Young Ah Lee, Jung Min Ko, Choong Ho Shin, Yun Jeong Lee","doi":"10.6065/apem.2448008.004","DOIUrl":"10.6065/apem.2448008.004","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the clinical characteristics and genetic features of childhood-onset congenital combined pituitary hormone deficiency (cCPHD) in Korean patients.</p><p><strong>Methods: </strong>We retrospectively analyzed 444 patients diagnosed with childhood-onset CPHD at a tertiary center between 1994 and 2021. After excluding acquired case, 43 patients with cCPHD were enrolled. Anthropometric measurements, hormone evaluations, brain magnetic resonance imaging (MRI), extrapituitary phenotypes, and adult outcomes were analyzed. Genetic analyses were performed on 26 patients using a targeted gene panel or whole exome sequencing.</p><p><strong>Results: </strong>Mean age at diagnosis was 3.2 years, and 41.9% were diagnosed at less than 1 year old. Short stature was the most frequent (37.2%) initial presentation, and mean height z-score was -2.4. More than half (n=23, 53.5%) of patients had neonatal features suggestive of hypopituitarism; however, only 15 (65.2%) were diagnosed in infancy. Growth hormone deficiency (GHD) was prevalent in 42 (97.7%), and 33 (76.7%) had 3 or more hormone deficiencies. Extrapituitary phenotypes were identified in 31 (72.1%). Brain MRI abnormalities correlated with a higher number of hormone deficiencies (P for trend 0.049) and were present in 33 patients (80.5%). Adult GHD was diagnosed in all 17 investigated patients, and metabolic disturbances were noted in 10 (58.9%). Pathogenic variants in POU1F1, GLI2, HESX1, TBC1D32, and ROBO1 were found in 5 (19.2%).</p><p><strong>Conclusion: </strong>Considering the high proportion of neonatal presentations, identification of the early neonatal features of hypopituitarism to manage pituitary and extrapituitary phenotypes is critical. The genetic etiology of cCPHD warrants further exploration.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 6","pages":"379-386"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725638/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to "Carotid intima-media thickness as surrogate marker: the clouding effect of submillimetric inaccuracies". 回复“颈动脉内膜-中膜厚度作为替代标记物:亚毫米误差的模糊效应”。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-12-01 Epub Date: 2024-12-31 DOI: 10.6065/apem.2448260.130
Sohyun Shin, Jaehyun Kim
{"title":"Reply to \"Carotid intima-media thickness as surrogate marker: the clouding effect of submillimetric inaccuracies\".","authors":"Sohyun Shin, Jaehyun Kim","doi":"10.6065/apem.2448260.130","DOIUrl":"10.6065/apem.2448260.130","url":null,"abstract":"","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 6","pages":"389-390"},"PeriodicalIF":2.8,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11725636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic approach to rickets: an Endocrine Society of Bengal (ESB) consensus statement. 佝偻病的诊断方法:孟加拉内分泌学会(ESB)共识声明。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-10-01 Epub Date: 2024-10-31 DOI: 10.6065/apem.2448044.022
Ajitesh Roy, Amarta Shankar Chowdhury, Arindam Ray, Arjun Baidya, Bibek Roychowdhury, Dasarathi Sarkar, Debmalya Sanyal, Indira Maisnam, Kaushik Biswas, Kaushik Pandit, Mainak Banerjee, Moutusi Raychaudhuri, Nilanjan Sengupta, Partha Pratim Chakraborty, Pradip Mukhopadhyay, Pradip Raychaudhuri, Pranab Kumar Sahana, Rajan Palui, Rana Bhattacharjee, Sarmistha Mukhopadhyay, Satinath Mukhopadhyay, Sayantan Ray, Soumik Goswami, Subhankar Chowdhury, Subhodip Pramanik, Subir Chandra Swar, Sujoy Ghosh, Sunetra Mondal, Tapas Chandra Das
{"title":"Diagnostic approach to rickets: an Endocrine Society of Bengal (ESB) consensus statement.","authors":"Ajitesh Roy, Amarta Shankar Chowdhury, Arindam Ray, Arjun Baidya, Bibek Roychowdhury, Dasarathi Sarkar, Debmalya Sanyal, Indira Maisnam, Kaushik Biswas, Kaushik Pandit, Mainak Banerjee, Moutusi Raychaudhuri, Nilanjan Sengupta, Partha Pratim Chakraborty, Pradip Mukhopadhyay, Pradip Raychaudhuri, Pranab Kumar Sahana, Rajan Palui, Rana Bhattacharjee, Sarmistha Mukhopadhyay, Satinath Mukhopadhyay, Sayantan Ray, Soumik Goswami, Subhankar Chowdhury, Subhodip Pramanik, Subir Chandra Swar, Sujoy Ghosh, Sunetra Mondal, Tapas Chandra Das","doi":"10.6065/apem.2448044.022","DOIUrl":"10.6065/apem.2448044.022","url":null,"abstract":"<p><p>Rickets, one of the leading causes of bony deformities and short stature, can be calciopenic (inciting event is defective intestinal calcium absorption) or phosphopenic (inciting event is phosphaturia). Early diagnosis and timely treatment of rickets are crucial for correction of the limb deformities. Guidelines exist for nutritional rickets, but the diagnosis and management of the relatively uncommon forms of rickets are complex. This consensus aims to formulate a simplified diagnostic approach for rickets, especially in resource-limited settings. The consensus statement has been formulated by a 29-member committee from the Endocrine Society of Bengal. The process included forming a working group, conducting a literature review, identifying controversies, drafting, and discussion at a consensus meeting. Participants rated their agreement with the clinical practice points, and a 70% consensus was required. Input integration and further review led to the final consensus statements. Children with suspected rickets should initially be examined for distinctive skeletal deformities. The diagnosis of rickets should be confirmed with characteristic radiographic abnormalities. It is advisable to order tests for serum calcium, inorganic phosphorus (Pi), liver function, 25-hydroxyvitamin D (25OHD), parathyroid hormone, creatinine, and potassium in all patients with rickets. In cases of refractory rickets, it is also recommended that assessments be conducted for spot urine calcium, Pi, creatinine, and, blood gas analysis. In children with rickets and metabolic acidosis, tests for glycosuria, uricosuria, aminoaciduria, low molecular weight proteinuria, and albuminuria should be conducted. In children with resistant calciopenic rickets and sufficient serum 25OHD levels, serum 1,25(OH)2D concentration should be tested. 1,25(OH)2 D and fibroblast growth factor 23 estimation is useful for certain forms of phosphopenic rickets.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 5","pages":"284-307"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors for thyroid dysfunction after discontinuation of levothyroxine in children and adolescents with Hashimoto thyroiditis. 桥本氏甲状腺炎儿童和青少年停用左甲状腺素后出现甲状腺功能障碍的预测因素。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-10-01 Epub Date: 2024-10-31 DOI: 10.6065/apem.2346204.102
Min Jee Kim, Yun Jeong Lee, Yunsoo Choe, Choong Ho Shin, Young Ah Lee
{"title":"Predictors for thyroid dysfunction after discontinuation of levothyroxine in children and adolescents with Hashimoto thyroiditis.","authors":"Min Jee Kim, Yun Jeong Lee, Yunsoo Choe, Choong Ho Shin, Young Ah Lee","doi":"10.6065/apem.2346204.102","DOIUrl":"10.6065/apem.2346204.102","url":null,"abstract":"<p><strong>Purpose: </strong>Few data on the clinical course after levothyroxine (L-T4) discontinuation in pediatric patients with Hashimoto thyroiditis (HT) are available. We investigated outcomes and predictors for successful withdrawal from L-T4 among children with HT.</p><p><strong>Methods: </strong>Among 168 patients diagnosed with HT between January 2000 and March 2021 at Seoul National University Children's Hospital and in whom L-T4 therapy was initiated during childhood, we attempted to discontinue this therapy in 47, 3 boys and 44 girls. L-T4 was restarted when patients developed overt or subclinical hypothyroidism (thyroid-stimulating hormone [TSH] levels≥10 mIU/L) after L-T4 discontinuation.</p><p><strong>Results: </strong>Median age at discontinuation was 15.4 years (12.7-18.4 years) with a median duration of L-T4 therapy of 47 months (20.3-80.3 months). During the median 30 months of follow-up (10.6-61.0 months) after L-T4 discontinuation, 33 (70.2%) developed thyroid dysfunction. Among these patients, 17 were eventually restarted on L-T4. TSH levels over 50 mIU/L at L-T4 initiation (hazard ratio, HR 3.5, P=0.002), age under 12 years at L-T4 discontinuation (HR 11.1, P=0.0001), and TSH levels higher than the upper 50% of normal (above 2.25 mIU/L in the present study) at L-T4 discontinuation (HR 2.7, P=0.014) were significantly predictive for overt hypothyroidism or subclinical hypothyroidism after L-T4 discontinuation. In addition, age under 12 years at L-T4 discontinuation was only predictive factor for restarting L-T4 medication (HR 4.3, P=0.012).</p><p><strong>Conclusion: </strong>L-T4 discontinuation in pediatric patients with HT resulted in thyroid dysfunction in 70.2% of cases; 36.2% of patients who attempted discontinuation required resumption of L-T4. Older age and lower TSH levels at L-T4 discontinuation were advantageous for successful withdrawal.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 5","pages":"337-343"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Deciphering the mystery of CHNG3". 关于&quot;破译 CHNG3 之谜&quot.的评论。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-10-01 Epub Date: 2024-10-31 DOI: 10.6065/apem.2424093edi05
Chong Kun Cheon
{"title":"Commentary on &quot;Deciphering the mystery of CHNG3&quot.","authors":"Chong Kun Cheon","doi":"10.6065/apem.2424093edi05","DOIUrl":"10.6065/apem.2424093edi05","url":null,"abstract":"","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 5","pages":"277-278"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the mystery of CHNG3. 破解 CHNG3 之谜。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-10-01 Epub Date: 2024-10-31 DOI: 10.6065/apem.2448186.093
Satoshi Narumi
{"title":"Deciphering the mystery of CHNG3.","authors":"Satoshi Narumi","doi":"10.6065/apem.2448186.093","DOIUrl":"10.6065/apem.2448186.093","url":null,"abstract":"<p><p>Congenital hypothyroidism (CH), characterized by insufficient thyroid hormone production due to abnormalities in the hypothalamic-pituitary-thyroid axis, is the most common congenital endocrine disorder. We previously conducted comprehensive genetic screening of 102 patients with permanent CH born in Kanagawa Prefecture, Japan and identified mutations in several genes in 19 CH patients, including defects in genes encoding dual oxidase 2, thyroglobulin, thyrotropin receptor, thyroid peroxidase, and paired-box 8. Despite these findings, approximately 80% of cases remain unexplained. CH pedigrees unexplained by known genetic forms of CH have been reported in the literature and registered as congenital hypothyroidism, nongoitrous, 3 (CHNG3; %609893) in Online Mendelian Inheritance in Man. We also identified a Japanese pedigree of CH that was compatible with CHNG3. However, the exact genetic cause of CHNG3 was not revealed by standard analysis methods such as exome sequencing and array comparative genomic hybridization. We therefore took a combined approach and analyzed a total of 11 undiagnosed CH pedigrees by whole genome sequencing to analyze a 3-Mb linkage region, and found a disease-causing variant affecting a TTTG microsatellite in a noncoding region on chromosome 15. Further analysis revealed that 13.9% of 989 Japanese CH patients had abnormalities involving the TTTG microsatellite, with a substantial proportion (41.5%) of familial CH cases carrying these mutations. Identification of the genetic cause of CHNG3 provides new insights into the pathogenesis of CH, and highlights the need for continued exploration of noncoding genomic regions in Mendelian disorders of unknown etiology.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 5","pages":"279-283"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response of children with Turner syndrome with different types of karyotype abnormalities to growth hormone treatment. 不同类型核型异常的特纳综合征患儿对生长激素治疗的反应。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-10-01 Epub Date: 2024-10-31 DOI: 10.6065/apem.2346246.123
Jung Eun Choi, Mi Jung Park, Jeesuk Yu, Hae Soon Kim
{"title":"Response of children with Turner syndrome with different types of karyotype abnormalities to growth hormone treatment.","authors":"Jung Eun Choi, Mi Jung Park, Jeesuk Yu, Hae Soon Kim","doi":"10.6065/apem.2346246.123","DOIUrl":"10.6065/apem.2346246.123","url":null,"abstract":"<p><strong>Purpose: </strong>Short stature is the main characteristic of Turner syndrome (TS) patients and growth hormone (GH) therapy has been essential for achieving the final adult height (Ht). In the present study, the response of TS patients with different types of karyotype abnormalities to GH therapy was analyzed.</p><p><strong>Methods: </strong>The clinical parameters of 194 TS patients registered in the LG Growth Study were retrospectively reviewed. Data for 4 groups of subjects were obtained as follows: monosomy X (n=56); X structural abnormality (n=26); X mosaicism without structural abnormality (n=41); X mosaicism with structural abnormality (n=71). Clinical characteristics and growth response parameters were compared over 3 years of GH treatment.</p><p><strong>Results: </strong>The baseline Ht standard deviation score (SDS) of all patients was -2.85±0.86. The baseline Ht SDS, body mass index SDS, and chronological age (years)-bone age (years) were significantly different based on chromosomal abnormalities. The growth velocity (GV; cm/yr) in the first year was the highest and significantly different among the groups. The GV in the second year also showed an increase in the X mosaicism without structural abnormality group compared with the monosomy X group. The change in Ht SDS (ΔHt SDS) over 3 years was not statistically different between karyotypes.</p><p><strong>Conclusion: </strong>The response to 3 years of GH therapy did not differ based on the karyotype of TS patients although the initial Ht SDS was the lowest in the monosomy X group.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 5","pages":"308-315"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-COVID syndrome and type 2 diabetes mellitus in Kazakhstan: clinical manifestations and vaccine efficacy. 哈萨克斯坦的后 COVID 综合征和 2 型糖尿病:临床表现和疫苗疗效。
IF 2.8
Annals of Pediatric Endocrinology & Metabolism Pub Date : 2024-10-01 Epub Date: 2024-10-31 DOI: 10.6065/apem.2346228.114
Saule Altynbekova, Zhangentkhan Abylaiuly, Svetlana Bolshakova, Timur Davlyatshin, Aizat Aimakhanova
{"title":"Post-COVID syndrome and type 2 diabetes mellitus in Kazakhstan: clinical manifestations and vaccine efficacy.","authors":"Saule Altynbekova, Zhangentkhan Abylaiuly, Svetlana Bolshakova, Timur Davlyatshin, Aizat Aimakhanova","doi":"10.6065/apem.2346228.114","DOIUrl":"10.6065/apem.2346228.114","url":null,"abstract":"<p><strong>Purpose: </strong>In this article, we report the results of a survey investigating post-coronavirus disease 2019 (COVID-19) syndrome in patients with type 2 diabetes mellitus and the impacts of vaccination on long-term manifestations. From February 2022 to April 2023, a survey of patients with type 2 diabetes and people without diabetes who were treated for a coronavirus infection was conducted in Kazakhstan.</p><p><strong>Methods: </strong>Participants were invited via social media to voluntarily participate in this study. A total of 417 surveys were included in this study, comprising 212 patients with type 2 diabetes and 205 without diabetes. We compared persistent complaints after recovery in patients with and without diabetes mellitus (DM), as well as vaccination status.</p><p><strong>Results: </strong>The results of this study on self-reported symptoms of prolonged COVID show that more than half of those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Kazakhstan have at least one persistent symptom after recovery. Based on the list of prolonged COVID-19 symptoms reported by patients with type 2 DM (T2DM), exertional dyspnoea, fatigue, respiratory discomfort, headaches, and sleep disturbances are among the most common ongoing conditions, and in many cases last more than 3 months after COVID-19.</p><p><strong>Conclusion: </strong>Patients with T2DM experience more severe and prolonged symptoms than those without diabetes. Additionally, vaccination lowers COVID-19 hospitalization risk and decreases the need for adjusting hypoglycemic therapy, such as insulin treatment, after recovering from SARS-CoV-2 infection.</p>","PeriodicalId":44915,"journal":{"name":"Annals of Pediatric Endocrinology & Metabolism","volume":"29 5","pages":"325-336"},"PeriodicalIF":2.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11541094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142591762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信